# Eureka Biotech Call 2026

**Funder:** Health Holland
**Budget:** €400k–€750k per project (Dutch partners)
**Deadline:** 25 September 2026 (Central EUREKA submission + national documentation required; Dutch consortia encouraged to notify RVO and Health Holland in advance)
**Consortium:** Required — at least 2 Dutch partners (1 company + 1 research organisation) and at least 2 partners from a priority country (1 company + 1 research organisation); priority countries: Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland
**Application:** 2-stage: central EUREKA submission portal, then national submission portal
**TRL:** 4-7
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.health-holland.com/funding-opportunities/eureka-biotech-call-2026
**Last verified:** 27 April 2026

## Eligibility & scope

PPP subsidy for Dutch SMEs and research organisations participating in international R&D consortia focused on cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies (TRL 4–7). Healthcare providers and foundations are not eligible. International partners must secure their own funding. Co-funding (in-kind and/or cash) by all partners is required.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/health-holland-eureka-biotech-call-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.